Published in Medical Letter on the CDC and FDA, January 2nd, 2005
The number and shape of the regions is expected to figure prominently in how many private companies decide to participate in the new drug benefit for older and disabled Americans, the cornerstone of last year's Medicare law. The law's supporters hoped competition between plans would drive patient costs down and enhance benefits.
Insurers could bid to participate in one or all the regions.
The country would be divided into 34...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA